Hepatic α-smooth muscle actin expression in hepatitis C patients before and after interferon therapy

Hepato-Gastroenterology

Volumn 48, Issue 37, 2001, Pages 212-215

  Khan, M A ^a   Poulos, J E ^a   Brunt, E M ^a   Li, L ^a   Solomon, H ^a   Britton, R S ^a   Bacon, B R ^a   Di Bisceglie, A M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha smooth muscle actin; Fibrogenesis; Hepatitis C; Interferon; Stellate cell

Indexed keywords

ALPHA ACTIN; INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; STELLATE CELL;

ACTINS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH;

EID: 0035102060     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The treatment of chronic viral hepatitis
2. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
3. Hepatic lipocytes: The principal collagen producing cells of normal rat liver
4. Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes
5. Time-related distribution profiles of sulfated glycosaminoglycans in cells, cell surfaces, and media of cultured rat liver fat storing cells
6. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers
7. Transforming growth factor β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent tissue myofibroblasts and in quiescent and growing cultured fibroblasts
8. Mediators of hepatic fibrogenesis
9. Endothelin antagonism in experimental hepatic fibrogenesis. Implications for endothelin in the pathogenesis of wound healing
10. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
11. Phenotypic change in portal fibroblasts in biliary fibrosis
12. α-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma
13. Lipocytes and transitional cells in alcoholic liver disease: A morphometric study
14. Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis
15. α-smooth muscle actin expression in normal and fibrotic human livers
16. Rapid dedifferentiation of myofibroblasts during hepatic repair following chronic cholestatic injury
17. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C
18. The nomenclature of chronic active hepatitis: An obituary
19. Liver stellate cells in chronic viral hepatitis: The effect of interferon therapy
20. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts
21. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
22. New insight into the mechanisms of interferon α: An immunoregulatory and anti-inflammatory cytokine
23. Interferon alpha and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
24. Inhibition of rat hepatic lipocyte activation in culture by interferongamma
25. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis
26. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view